From formulation development to first in man: how to streamline the Pathway to Clinic®

Turning a promising compound into a drug product fit for first-in-human (FIH) trials is a complex, multi-step process that requires expertise in a variety of disciplines.

This webinar explains how Recipharm and CTC work together to provide pharmaceutical companies with a clear pathway from laboratory to clinic that covers early formulation development through FIH studies in a time efficient and cost-effective manner.

Watch the webinar by registering for on-demand below.
 
True
False